Prevalence of <scp>PD‐L1</scp> expression in head and neck squamous precancerous lesions: a systematic review and meta‐analysis
Ilaria Girolami, Liron Pantanowitz, Enrico Munari, Maurizio Martini, Riccardo Nocini, Nicola Bisi, Gabriele Molteni, Daniele Marchioni, Claudio Ghimenton, Matteo Brunelli, Albino Eccher
Abstract
Abstract Background Studies concerning programmed death‐ligand 1 (PD‐L1) expression in precancerous lesions of head and neck (HN) region have shown variable results. Methods We systematically reviewed the published evidence on PD‐L1 expression in HN precancerous lesions. Results Of 1058 original articles, 14 were included in systematic review and 9 in meta‐analysis. The pooled estimate of PD‐L1 expression was 48.25% (confidence interval [CI] 21.07‐75.98, I 2 98%, tau2 0.18). PD‐L1 expression appeared to be more frequent in precancerous lesions than in normal mucosa (risk ratio [RR] 1.65, CI 0.65‐4.03, I 2 91%, tau2 0.82) and less frequent than in invasive squamous cell carcinoma (RR 0.68, CI 0.43‐1.08, I 2 91%, tau2 0.22). Conclusions PD‐L1 expression could reflect a point of balance between host immune response and cancer escape ability. High heterogeneity and moderate quality suggest that further studies with larger sample size and more rigorous case selection will allow more precise assessment of PD‐L1 expression in HN precancerous lesions.